USA - Lundbeck told the Financial Times that the firm is taking new hard-line measures to block its use for lethal injection

Ulf Wiinberg, Lundbeck’s Ceo, told the Financial Times of London that the firm is taking new hard-line measures to block its use for lethal injection. Lundbeck Inc., which has U.S. headquarters in Deerfield, Ill., said this week that it will work through "specialist wholesalers" and include "end-user clause" restrictions in selling pentobarbital, also known by the brand name Nembutal. "Obviously, we would like to do the right thing,"